The annual research grants are part of the Alpha-1 Foundation's ongoing commitment to increase the understanding of alpha-1 antitrypsin deficiency
, a genetic disorder in which low levels of the A1PI protein can result in liver damage and emphysema.
Alpha-1 antitrypsin deficiency
is a hereditary condition that is characterized by a low level of alpha-1 protein in the blood and the lungs.
a global, diversified healthcare company ("Baxter") announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency
approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia[TM]".
3, 2015 /PRNewswire/-- The Alpha-1 Foundation is marking Alpha-1 Awareness Month, designed to increase knowledge about Alpha-1 Antitrypsin Deficiency
Plasma protein therapies, which include plasma-derived therapies and recombinant analogs, are used to treat chronic, life-threatening diseases including bleeding disorders, primary immune deficiencies, alpha-1 antitrypsin deficiency
and certain rare neurological disorders.
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency
She was treated for Alpha-1 Antitrypsin Deficiency
at Birmingham Children's Hospital after research there was boosted by funding from Action Medical Research.
DENVER - Screening for alpha-1 antitrypsin deficiency
has benefits in appropriately selected patients with lung disease and their family members, according to Dr.
A hereditary condition known as Alpha 1 Antitrypsin Deficiency
is causing her lungs to deteriorate.
They address diseases like Marfan and Goodpasture's syndromes, sarcoidosis, autoimmune pulmonary alveolar proteinosis, hereditary haemorrhagic telangiectasia, Hermansky-Pudlak syndrome, primary ciliary dyskinesia, cystic fibrosis, scleroderma lung disease, and alpha-1 antitrypsin deficiency
, and their epidemiology, genetic basis and molecular pathogenesis, animal models, clinical presentation, diagnosis, conventional management and treatment strategies, and future therapies and directions.
Recommendations for expensive treatments made for a genetic disorder called alpha-1 antitrypsin deficiency
should be withdrawn because the drugs have no benefit, scientists said.
Alpha 1 proteinase inhibitor is intended for therapy of congenital alpha 1 antitrypsin deficiency
, which leads to emphysema.